Walmart Inc. (NYSE: WMT) on Tuesday reported impressive earnings and revenue growth for the third quarter of 2022. The numbers also came in above the consensus estimates, sending the retail giant’s stock higher in the pre-market session soon after the announcement.
Third-quarter earnings, excluding special items, rose to $1.45 per share from $1.34 per share in the corresponding period of 2021. It was also above experts’ projection. Unadjusted net income was $3.1 billion or $1.11 per share, compared to $5.14 billion or $1.80 per share a year earlier.
At $140.5 billion, total revenues were up 4.3% year-over-year during the three-month period, which is above the estimates. U.S comparable store sales increased 9.2%.
Walmart’s stock gained Tuesday morning immediately after the earnings announcement, after closing the previous session lower.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings
Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key